GLP-1 therapies, or glucagon-like peptide-1 receptor agonists , represent a substantial shift in how we treat diabetes mellitus . These injectable drugs function to mimicking the body’s own GLP-1 https://bookmarksden.com/story21886505/glp-1-a-major-advance-in-diabetes-treatment